3627 results for «345»

Filter By

3627 results

Integrating FFRangio into your daily practice - Empowering wire-free insights

18 May 2023 – From EuroPCR 2023

In this session, dive into the world of FFRangio, from concept to clinical reality, and then analyze different cases in real practice to see how useful the physiology is, to try to understand why it is still so little used, and to learn how FFRangio could...

Integrating FFRangio

Management of PCI complications

16 May 2023 – From EuroPCR 2023

Listen to speakers explore the landscape of PCI complications, dissecting their impact, strategies for skillful management and ways to optimize patient outcomes. Advance your own understanding of this important problem and discover a range of approaches to mitigating it.

Management of PCI complications

Meaningful innovations in interventional cardiology

18 May 2023 – From EuroPCR 2023

In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!

Meaningful innovations

PCR London Valves 2021 – Welcome message

Read words from #PCRLV Course Directors for the on-site and online participants
PCR London Valves 2021 – Welcome message

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

Real-world outcomes with the PASCAL Platform in TR

03 Dec 2021

The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...

Real-world outcomes with the PASCAL Platform in TR

One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation

22 Mar 2022

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.

Alessandro Sticchi

Author

Alessandro Sticchi
Luigi Biasco

Author

Luigi Biasco
One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation
Didn’t find what you were looking for?